# Table ID: b3d63fb06110ad7e91c9e765227c1d27

Financial data for June 30, 2019 and 2018. All monetary amounts are in thousands unless otherwise specified.

| Item | June 30, 2019 | June 30, 2018 |
|------|---------------|---------------|
| **Deferred tax assets.** | | |
| Non-capital loss carryforwards | 161119 | 129436 |
| Capital loss carryforwards | 155 | 417 |
| Undeducted scientific research and development expenses | 137253 | 123114 |
| Depreciation and amortization | 683777 | 829369 |
| Restructuring costs and other reserves | 17845 | 17202 |
| Deferred revenue | 53254 | 62726 |
| Other | 59584 | 57461 |
| Total deferred tax asset | 1112987 | 1219725 |
| Valuation Allowance | $(77 | $(80 |
| **Deferred tax liabilities.** | | |
| Scientific research and development tax credits | $(14 | $(13 |
| Other | -72599 | -82668 |
| Deferred tax liabilities | $(87 | $(96 |
| Net deferred tax asset | 948578 | 1042791 |
| **Comprised of:.** | | |
| Long-term assets | 1004450 | 1122729 |
| Long-term liabilities | -55872 | -79938 |
